Itamar Medical Ltd. announced that WatchPAT™300 Home Sleep Apnea Testing (HSAT) device has been granted PMDA approval for use in the Japanese market, effective September 14, 2020. Japan represents the second large potential patient market for Itamar Medical behind the U.S, where the company currently operates. The WatchPAT™300, an easy-to-use, non-invasive HSAT device, will be made available in Japan through Philips Japan Co., Itamar Medical’s exclusive Japanese distributor since 2014.